Поисковый запрос: (<.>S=ЭПИДОКСОРУБИЦИН<.>) |
Общее количество найденных документов : 55
Показаны документы с 1 по 20
|
|
1.
| Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach // J. Chemother, 1994. Vol. 6, N 2.-С.147-151
|
2.
| Pharmacological influence on chemical - induced neoangiogenesis // Онкология, 1994. Vol. 31, N 1-4.-С.16
|
3.
| The clinical impact of FEM regimen (5-fluorouracil, 4-epidoxorubicin and mitomycin-C) in advanced gastric cancer patients // Anticancer Res., 1995. Vol. 15, N 6b.-С.2781-2783
|
4.
| Endoluminal instillation of epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours // Anticancer Res., 1996. Vol. 16, N 1.-С.537-540
|
5.
| Endoluminal instillation of epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours // Anticancer Res., 1996. Vol. 16, N 1.-С.537-540
|
6.
| Metabolic interaction between epidoxorubicin and paclitaxel in cancer patients // Pharmacol. Res., 1997. Vol. 35, Suppl..-С.101
|
7.
| A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer // J. Chemother., 1998. Vol. 10, N 4.-С.326-330
|
8.
| Yang Лейковорин и 5-фторурацил с оксалиплатином и эпидоксорубицином в качестве терапии первой линии распространенного рака желудка // Zhongliu fangzhi zazhi, 2002. Vol. 9, N 1.-С.76-78
|
9.
| The acute effect of doxorubicin and its analogue - 4'-epidoxorubicin on circulatory system in rabbits // Pol. J. Pharmacol. and Pharm., 1988. Vol. 40, N 2.-С.159-165
|
10.
| Abbruzzese James L. Recent approaches to the systemic therapy of advanced colorectal carcinoma // Cancer Bull., 1988. Vol. 40, N 4.-С.238-243
|
11.
| Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer // Cancer Chemother. and Pharmacol., 1989. Vol. 23, N 1.-С.51-53
|
12.
| Ineficacia del cisplatin y la epidoxorubicina como tratamiento de la leucemia aguda linfoblastica resistente del adulto // Sangre, 1988. Vol. 33, N 6.-С.522-524
|
13.
| Нерсесян А.К. Цитогенетическое действие противоопухолевого антракциклинового антибиотика 4'-эпидоксорубицина // Антибиотики и химиотерапия, 1989. Т. 34, N 3.-С.216-217
|
14.
| Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients // Anticancer. Res., 1989. Vol. 9, N 1.-С.193-196
|
15.
| Rizzo A. Valutazione degli effetti cardiotossici di doxorubicina ed epidoxorubicina in pazienti portatori di tumori solidi // Acta med. mediterr, 1988. Vol. 4, N 3.-С.227-236
|
16.
| Tidefelt Ulf. Comparison of the intracellular pharmacokinetics of doxorubicin and 4'-epi-doxorubicin in patients with acute leukemia // Cancer Chemother. and Pharmacol., 1989. Vol. 24, N 4.-С.225-229
|
17.
| Pharmacokinetic and pharmacodynamic studies with 4'-epidoxorubicin in nasopharyngeal carcinoma patients // Cancer Chemother. and Pharmacol., 1989. Vol. 24, N 5.-С.332-337
|
18.
| Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin // F. Cancer Res. and Clin. Oncol., 1989. Vol. 115, N 4.-С.373-378
|
19.
| Chemoembolisation with intra-arterial lipiodol and 4-epidoxorubicin in treatment of inoperable hepatocellular carcinoma // 4 Int. Conf. Adv. Reg. Cancer Therapy. -Trostberg, 1989.-С.6С. 32
|
20.
| Pharmacokinetics and central haemodynamic effects of doxorubicin and 4'-epi-doxorubicin in the pig // Acta oncol., 1989. Vol. 28, N 5.-С.709-714
|
&uf('+1W2226#',v2226), ?>
|
|